Roderick L Beijersbergen (Roderick Beijersbergen)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 21

Top Topics

Papillary Thyroid

Dna Damage Response

Cell Proliferation

Top Venues

Nature communications

Nucleic acids research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Ruben Schep, Max Trauernicht, Xabier Vergara, Anoek Friskes, Ben Morris, Sebastian Gregoricchio, Stefano G Manzo, Wilbert Zwart, Roderick L Beijersbergen, René H Medema, Bas van Steensel
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing. Nucleic acids research 52 (15) (2024)
Ruben Schep, Max Trauernicht, Xabier Vergara, Anoek Friskes, Ben Morris, Sebastian Gregoricchio, Stefano G Manzo, Wilbert Zwart, Roderick L Beijersbergen, René H Medema, Bas van Steensel
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing. Nucleic acids research (2024)
Ruben Schep, Max Trauernicht, Xabier Vergara, Anoek Friskes, Ben Morris, Sebastian Gregoricchio, Stefano G Manzo, Wilbert Zwart, Roderick L Beijersbergen, René H Medema, Bas van Steensel
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing. Nucleic acids research 52 (15) (2024)
Xabier Vergara, Anna G Manjón, Marcel de Haas, Ben Morris, Ruben Schep, Christ Leemans, Anoek Friskes, Roderick L Beijersbergen, Mathijs A Sanders, René H Medema, Bas van Steensel
Widespread chromatin context-dependencies of DNA double-strand break repair proteins. Nature communications 15 (1) (2024)
Matheus Henrique Dias, Anoek Friskes, Siying Wang, João M Fernandes Neto, Frank van Gemert, Soufiane M C Mourragui, Chrysa Papagianni, Hendrik J Kuiken, Sara Mainardi, Daniel Alvarez-Villanueva, Cor Lieftink, Ben Morris, Anna Dekker, Emma van Dijk, Lieke H S Wilms, Marcelo Santos da Silva, Robin A Jansen, Antonio Mulero-Sanchez, Elke Malzer, August Vidal Bel, Cristina Santos, Ramón Salazar, Rosangela A M Wailemann, Thompson E P Torres, Giulia De Conti, Jonne A Raaijmakers, Petur Snaebjornsson, Sheng-Xian Yuan, Wenxin Qin, John S Kovach, Hugo Aguirre Armelin, Hein Te Riele, Alexander van Oudernaarden, Haojie Jin, Roderick L Beijersbergen, Alberto Villanueva, René H Medema, René Bernards
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy. Cancer discovery 14 (7) (2024)
Ruben Schep, Max Trauernicht, Xabier Vergara, Anoek Friskes, Ben Morris, Sebastian Gregoricchio, Stefano G Manzo, Wilbert Zwart, Roderick L Beijersbergen, René H Medema, Bas van Steensel
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing. Nucleic acids research 52 (15) (2024)
Xabier Vergara, Anna G Manjón, Marcel de Haas, Ben Morris, Ruben Schep, Christ Leemans, Anoek Friskes, Roderick L Beijersbergen, Mathijs A Sanders, René H Medema, Bas van Steensel
Widespread chromatin context-dependencies of DNA double-strand break repair proteins. Nature communications 15 (1) (2024)
Xabier Vergara, Anna G Manjón, Marcel de Haas, Ben Morris, Ruben Schep, Christ Leemans, Anoek Friskes, Roderick L Beijersbergen, Mathijs A Sanders, René H Medema, Bas van Steensel
Widespread chromatin context-dependencies of DNA double-strand break repair proteins. Nature communications 15 (1) (2024)
Xabier Vergara, Anna G Manjón, Marcel de Haas, Ben Morris, Ruben Schep, Christ Leemans, Anoek Friskes, Roderick L Beijersbergen, Mathijs A Sanders, René H Medema, Bas van Steensel
Widespread chromatin context-dependencies of DNA double-strand break repair proteins. Nature communications 15 (1) (2024)
Matheus Henrique Dias, Anoek Friskes, Siying Wang, João M Fernandes Neto, Frank van Gemert, Soufiane M C Mourragui, Chrysa Papagianni, Hendrik J Kuiken, Sara Mainardi, Daniel Alvarez-Villanueva, Cor Lieftink, Ben Morris, Anna Dekker, Emma van Dijk, Lieke H S Wilms, Marcelo Santos da Silva, Robin A Jansen, Antonio Mulero-Sanchez, Elke Malzer, August Vidal Bel, Cristina Santos, Ramón Salazar, Rosangela A M Wailemann, Thompson E P Torres, Giulia De Conti, Jonne A Raaijmakers, Petur Snaebjornsson, Sheng-Xian Yuan, Wenxin Qin, John S Kovach, Hugo Aguirre Armelin, Hein Te Riele, Alexander van Oudernaarden, Haojie Jin, Roderick L Beijersbergen, Alberto Villanueva, René H Medema, René Bernards
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy. Cancer discovery 14 (7) (2024)
Matheus Henrique Dias, Anoek Friskes, Siying Wang, João M Fernandes Neto, Frank van Gemert, Soufiane M C Mourragui, Chrysa Papagianni, Hendrik J Kuiken, Sara Mainardi, Daniel Alvarez-Villanueva, Cor Lieftink, Ben Morris, Anna Dekker, Emma van Dijk, Lieke H S Wilms, Marcelo Santos da Silva, Robin A Jansen, Antonio Mulero-Sanchez, Elke Malzer, August Vidal Bel, Cristina Santos, Ramón Salazar, Rosangela A M Wailemann, Thompson E P Torres, Giulia De Conti, Jonne A Raaijmakers, Petur Snaebjornsson, Sheng-Xian Yuan, Wenxin Qin, John S Kovach, Hugo Aguirre Armelin, Hein Te Riele, Alexander van Oudernaarden, Haojie Jin, Roderick L Beijersbergen, Alberto Villanueva, René H Medema, René Bernards
Paradoxical activation of oncogenic signaling as a cancer treatment strategy. Cancer discovery (2024)
Ruben Schep, Max Trauernicht, Xabier Vergara, Anoek Friskes, Ben Morris, Sebastian Gregoricchio, Stefano G Manzo, Wilbert Zwart, Roderick L Beijersbergen, René H Medema, Bas van Steensel
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing. Nucleic acids research (2024)
Matheus Henrique Dias, Anoek Friskes, Siying Wang, João M Fernandes Neto, Frank van Gemert, Soufiane M C Mourragui, Chrysa Papagianni, Hendrik J Kuiken, Sara Mainardi, Daniel Alvarez-Villanueva, Cor Lieftink, Ben Morris, Anna Dekker, Emma van Dijk, Lieke H S Wilms, Marcelo Santos da Silva, Robin A Jansen, Antonio Mulero-Sanchez, Elke Malzer, August Vidal Bel, Cristina Santos, Ramón Salazar, Rosangela A M Wailemann, Thompson E P Torres, Giulia De Conti, Jonne A Raaijmakers, Petur Snaebjornsson, Sheng-Xian Yuan, Wenxin Qin, John S Kovach, Hugo Aguirre Armelin, Hein Te Riele, Alexander van Oudernaarden, Haojie Jin, Roderick L Beijersbergen, Alberto Villanueva, René H Medema, René Bernards
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy. Cancer discovery 14 (7) (2024)
Esmée P Hoefsmit, Paula T van Royen, Disha Rao, Johanna A Stunnenberg, Petros Dimitriadis, Cor Lieftink, Ben Morris, Elisa A Rozeman, Irene L M Reijers, Ruben Lacroix, Huma Shehwana, Maarten A Ligtenberg, Roderick L Beijersbergen, Daniel S Peeper, Christian U Blank
Inhibitor of apoptosis proteins (IAP) antagonist induces T-cell proliferation after cross-presentation by dendritic cells. Cancer immunology research (2023)
Roderick L Beijersbergen
Old drugs with new tricks. Nature cancer 1 (2) (2022)
Liqin Wang, Haojie Jin, Fleur Jochems, Siying Wang, Cor Lieftink, Isabel Mora Martinez, Giulia De Conti, Finn Edwards, Rodrigo Leite de Oliveira, Arnout Schepers, Yang-Yang Zhou, Jiaojiao Zheng, Wei Wu, Xingling Zheng, Shengxian Yuan, Jing Ling, Kathy Jastrzebski, Matheus Dos Santos Dias, Ji-Ying Song, Patrick N H Celie, Hideo Yagita, Ming Yao, Wei-Ping Zhou, Roderick L Beijersbergen, Wenxin Qin, René Bernards
cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis. Nature cancer 3 (11) (2022)
Martin F M de Rooij, Yvonne J Thus, Nathalie Swier, Roderick L Beijersbergen, Steven T Pals, Marcel Spaargaren
A loss-of-adhesion CRISPR-Cas9 screening platform to identify cell adhesion-regulatory proteins and signaling pathways. Nature communications 13 (1) (2022)
Marta Llaurado Fernandez, E Marielle Hijmans, Annemiek M C Gennissen, Nelson K Y Wong, Shang Li, G Bea A Wisman, Aleksandra Hamilton, Joshua Hoenisch, Amy Dawson, Cheng-Han Lee, Madison Bittner, Hannah Kim, Gabriel E DiMattia, Christianne A R Lok, Cor Lieftink, Roderick L Beijersbergen, Steven de Jong, Mark S Carey, René Bernards, Katrien Berns
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition. Molecular cancer therapeutics 21 (12) (2022)
Miguel Vizoso, Colin E J Pritchard, Lorenzo Bombardelli, Bram van den Broek, Paul Krimpenfort, Roderick L Beijersbergen, Kees Jalink, Jacco van Rheenen
A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing. Nature communications 13 (1) (2022)
Stefan Prekovic, Karianne Schuurman, Isabel Mayayo-Peralta, Anna G Manjón, Mark Buijs, Selçuk Yavuz, Max D Wellenstein, Alejandro Barrera, Kim Monkhorst, Anne Huber, Ben Morris, Cor Lieftink, Theofilos Chalkiadakis, Ferhat Alkan, Joana Silva, Balázs Győrffy, Liesbeth Hoekman, Bram van den Broek, Hans Teunissen, Donna O Debets, Tesa Severson, Jos Jonkers, Timothy E Reddy, Karin E de Visser, William James Faller, Roderick L Beijersbergen, Maarten Altelaar, Elzo de Wit, Rene Medema, Wilbert Zwart
Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer. Nature communications 12 (1) (2021)
Haojie Jin, Yaoping Shi, Yuanyuan Lv, Shengxian Yuan, Christel F A Ramirez, Cor Lieftink, Liqin Wang, Siying Wang, Cun Wang, Matheus Henrique Dias, Fleur Jochems, Yuan Yang, Astrid Bosma, E Marielle Hijmans, Marnix H P de Groot, Serena Vegna, Dan Cui, Yang-Yang Zhou, Jing Ling, Hui Wang, Yuchen Guo, Xingling Zheng, Nikita Isima, Haiqiu Wu, Chong Sun, Roderick L Beijersbergen, Leila Akkari, Wei-Ping Zhou, Bo Zhai, Wenxin Qin, René Bernards
EGFR activation limits the response of liver cancer to lenvatinib. Nature 595 (7869) (2021)